LAS VEGAS — A Nevada state court judge overseeing a jury trial over the alleged bladder cancer risks of Takeda Pharmaceutical Co Ltd.’s blockbuster diabetes medication drug Actos announced Oct. 7, 2015 that Takeda

An Actos settlement of $2.4 billion to pay some 9,000 cases brought by U.S. citizens who allege Actos’ maker Takeda concealed the drug's cancer risks. Actos is a diabetes medicine sold by the Osaka,

Takeda Pharmaceutical Company’s new diabetes treatment was not approved for sale in the United States, as U.S. regulators asked for more information on the medicine than other countries. The Food and Drug Administration requested

Actos LawsuitThe first court hearing regarding an Actos lawsuit has been scheduled by a federal judge in Louisiana. The claim is that Actos, a diabetes drug, is related to an increased risk of bladder

Three couples have filed lawsuits that claim Takeda Pharmaceutical Company Limited, the manufacturer of Actos, hid the fact that the drug has been associated with a risk of cancer. The three men involved in